These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10783412)

  • 41. [Myocardial infarction, late fibrinolysis and resolving cerebral embolism].
    Lescure M; Lagorce P; Caussanel JP; Malbec M
    Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):25-7. PubMed ID: 8480981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease, myocardial infarction and coronary artery revascularization.
    Wong D; Harder J; Jadavji T
    Can J Cardiol; 2005 May; 21(7):601-4. PubMed ID: 15940359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improve AMI (acute myocardial infarction) therapy by working with ICU, ED.
    Hosp Case Manag; 1996 Nov; 4(11):172-5. PubMed ID: 10172888
    [No Abstract]   [Full Text] [Related]  

  • 46. Alteplase and anistreplase in acute myocardial infarction.
    Drug Ther Bull; 1989 Dec; 27(26):101-3. PubMed ID: 2519323
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lingual haematoma after thrombolysis for acute myocardial infarction].
    Jaffrelot M; Bourrigan P; Cracan A; Dewilde J; Mehu G
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):306-7. PubMed ID: 15792570
    [No Abstract]   [Full Text] [Related]  

  • 48. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thrombolysis in acute myocardial infarction].
    Rutsch W
    Dtsch Med Wochenschr; 1994 Sep; 119(36):1220-1. PubMed ID: 8082591
    [No Abstract]   [Full Text] [Related]  

  • 51. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful intravenous streptokinase treatment of a child with Kawasaki disease complicated by acute myocardial infarction.
    Liang CD; Huang SC; Su WJ; Chen HY; Lee CH
    Cathet Cardiovasc Diagn; 1995 Jun; 35(2):139-45. PubMed ID: 7656308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction.
    Bogaty P; Buller CE; Dorian P; O'Neill BJ; Armstrong PW;
    CMAJ; 2004 Oct; 171(9):1039-41. PubMed ID: 15505262
    [No Abstract]   [Full Text] [Related]  

  • 55. Optimal dosage regimens of tissue-type plasminogen activator.
    Agnelli G; Hirsh J
    Semin Thromb Hemost; 1987 Apr; 13(2):160-2. PubMed ID: 3114884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracoronary urokinase and post-thrombolytic regimen in an infant with Kawasaki disease and acute myocardial infarction.
    Katayama F; Hiraishi S; Takeda N; Misawa H
    Heart; 1997 Dec; 78(6):621-2. PubMed ID: 9470886
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Chelluri L; Sirio CA; Angus DC
    N Engl J Med; 1994 Feb; 330(7):505; author reply 505-6. PubMed ID: 8289862
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator.
    Schumacher B; Belfort MA; Card RJ
    Am J Obstet Gynecol; 1997 Mar; 176(3):716-9. PubMed ID: 9077638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombolytic therapy for myocardial infarction.
    Andreotti F
    N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract]   [Full Text] [Related]  

  • 60. Tissue plasminogen activator for coronary thrombosis.
    DiPalma JR
    Am Fam Physician; 1988 Mar; 37(3):291-5. PubMed ID: 3126630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.